NLS Pharmaceutics AG

City:

Stans

Country:

Switzerland

Published Applications:

Last publication date:

2021-06-03

Patent Grants:

Last grant date:

2023-03-07

Top Inventors for applications by NLS Pharmaceutics AG

These are the the leading inventors for applications assigned to NLS Pharmaceutics AG:

Alexander C. ZWYER 2 Teufen, Switzerland
Scott BRANTLEY 1 Apex, NC United States
Eric Konofal 1 Senlis, France
Lewis P. AMSEL 1 Sarasota, FL United States

Virginia SCHMITH 1 Wrightsville Beach, NC United States
Bruno Figadere 1 Saint Cheron, France

Recent patent applications by NLS Pharmaceutics AG

NLS Pharmaceutics AG based in Stans, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-06-03 ✅ Patent 11,596,622 granted on 2023-03-07

US20210161865A1

Human necessities

Mazindol treatment for heroin dependence and substance use disorder

#2 | 2021-02-11 ✅ Patent 11,207,271 granted on 2021-12-28

US20210038521A1

Human necessities

Mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)

#3 | 2018-08-02 ✅ Patent 10,456,387 granted on 2019-10-29

US20180214436A1

Human necessities

Phacetoperane for treating of attention deficit hyperactivity disorder

Also check out NLS Pharmaceutics AG's (Stans, Switzerland) applicant profile with 3 patent applications submitted.

AssigneeID:

311048 ⎘